Showing posts with label CoronavirusOutbreak. Show all posts
Showing posts with label CoronavirusOutbreak. Show all posts

Friday, July 24, 2020

What will it take to make effective Covid-19 vaccine?

With the global pandemic still in full swing, scientists around the world are working to develop an effective vaccine for Covid-19 virus in record time but they don’t all agree on how to get there and what “effective” really means.



 

In the study, published in the journal Chemical & Engineering News (C&EN), the experts spoke with researchers, doctors, and business leaders to shed light on some of the challenges vaccine developers are facing.

 

“As of mid-July, the World Health Organisation (WHO) reported that over 160 vaccine programs were in progress, an unprecedented effort toward a common goal,” wrote the study author Ryan Cross from C&EN in the US.

 

For SARS-CoV-2, the virus that causes Covid-19, that part is the spike protein, which the virus uses to attach itself to human cells.

 

Both types of methods can be time-consuming, and traditional approaches are potentially dangerous because companies need to grow large amounts of virus.

 

This has caused some scientists to turn to experimental gene-based vaccines, the experts said. Researchers put the genetic code for the spike protein into harmless viruses that act as vessels, or simply use DNA or RNA to deliver the genetic information to human cells.

 

Human cells would use these instructions to make the spike protein, which would trigger an immune response.

 

These types of vaccines are very fast for scientists to design and make, but the technology is largely unproven, and it remains to be seen whether these kinds of vaccines are effective, Cross wrote.

 

Furthermore, there are many different modifications that scientists can make to the spike protein, which could change how our immune systems respond to the real virus.

 

According to Cross, vaccine makers are focusing on the ability of candidates to produce high levels of neutralizing antibodies that would prevent the virus from entering cells.

 

But this area of vaccine research also faces challenges. For example, the methods for quantifying the antibody response in the laboratory are not ideal.

 

In addition, it’s unclear just how much neutralization is good enough and for how long the effect would last.

 

“If antibody levels aren’t high enough, a person might only be left with partial immunity, which could prevent severe symptoms but still leave them with the ability to infect others and what works in one person might not work well in another,” Cross said.

 

Questions about safety still loom, and experts warn that moving too fast with an unsafe vaccine could shake public confidence.

 

 

Friday, April 17, 2020

Africa could be next coronavirus epicentre: WHO

The World Health Organization (WHO) on Friday that Africa could become the next epicentre of the coronavirus pandemic as there was a sharp rise in the number of COVID-19 cases in the past week.

There have been almost 1,000 deaths and more than 18,000 infections across Africa so far, although these rates were far lower than those seen in parts of Europe and the US.

The WHO’s Africa director, Matshidiso Moeti, told the BBC that the organization had witnessed the virus spreading from capital cities to “the hinterland” in South Africa, Nigeria, Ivory Coast, Cameroon, and Ghana.

She said they were focusing on prevention rather than treating the virus because African countries don’t have the capacity to treat many coronavirus patients.

“We want to minimize the proportion of people who get to the point of needing critical care in an ICU because we know that these types of facilities are not adequate by any means in the majority of African countries,” she told the BBC.

“I have to say the issue of ventilators is one of the biggest challenges that the countries are facing.”

For patients critically ill with COVID-19, access to a ventilator could be a matter of life or death.

One of the first recorded deaths from coronavirus in Africa was Zimbabwean journalist Zororo Makamba in March.

The local authorities in the capital, Harare, said that they did not have a ventilator to treat him.

There were also fears that the disease could spread rapidly in overcrowded areas where it is impossible to practice social distancing and where many do not have access to clean water and soap.




Monday, January 27, 2020

China coronavirus toll reaches 80, 2,744 infected

Chinese health authorities on Monday said that 80 people have died due to the novel coronavirus (2019-nCoV) outbreak in the country, with 2,744 confirmed cases.



The National Health Commission said that of the infected, 461 were in critical condition, Xinhua news agency reported.

Sunday saw 769 new confirmed cases, 3,806 new suspected cases and 24 deaths (all in Hubei province), the Commission revealed.

By the end of Sunday, 51 people had recovered and there were currently a total of 5,794 suspected cases.

Meanwhile, at least 32,799 close contacts have been traced, the Commission said, adding that among them, 583 were discharged from medical observation on Sunday, with 30,453 others still under medical observation.

The figures also showed that 17 confirmed cases had been reported in Hong Kong (eight), Macao (five) and Taiwan (four).

Outside of China, there are currently eight confirmed cases in Thailand (five of which have been discharged from hospital); five in the US; four each in Australia, Singapore, Malaysia, Taiwan, France and Japan (one cured); three in South Korea; two in Vietnam; and one each in Nepal and Canada.

Pakistan has five suspected cases who are all under observation.

China has announced the extension of the Spring Festival holiday until February 2, amid its efforts to curb the spread of the novel coronavirus.

Universities, primary and secondary schools, and kindergartens across the country will postpone the start of the semester, said a State Council General Office circular, adding that the specific time for the semester start will be unveiled by respective education authorities.
The measure is taken to help reduce mass gatherings, curb the spread of the novel coronavirus, and to better safeguard the safety and health of the Chinese people, according to the circular.

The symptoms of the new coronavirus, provisionally designated by the WHO as 2019-nCoV, are similar to those of cold but may be accompanied by fever and fatigue, dry cough and dyspnea (shortness of breath).